Literature DB >> 29466784

Clinical, Hormonal, and Genetic Evaluation of Idiopathic Nonobstructive Azoospermia and Klinefelter Syndrome Patients.

Shin Y Kim1, Bom Y Lee, Ah R Oh, So Y Park, Hyo S Lee, Ju T Seo.   

Abstract

To investigate the clinical, hormonal, and genetic factors in infertile men with idiopathic nonobstructive azoospermia (NOA) or azoospermic Klinefelter syndrome (KFS), a total of 556 and 96 patients, respectively, were included in this study. All patient samples were analyzed cytogenetically. Serum reproductive hormone levels were measured. Microdeletions in the azoospermia factor (AZF) region of the Y chromosome were detected by multiplex PCR using 16 specific sequence-tagged sites. FSH and LH levels in both NOA and KFS patients were significantly higher than the normal range, and the testosterone level in KFS patients was significantly lower. Ninety-two (95.8%) of the KFS patients showed non-mosaic 47,XXY karyotypes and 47,XXY,inv(9)(p11.1q13); the other KFS patients had mosaic karyotypes of 47,XXY/46,XY, 47,XXY/46,XX, and 47,XXY/48,XXXY/46,XX. Among the 556 idiopathic NOA patients with normal karyotypes, 67 (12.05%) had microdeletions in the AZF region of the Y chromosome. Microdeletions were most frequently detected in the AZFc region, followed by AZFa, AZFb, AZFbc, and partial AZFc deletions. However, Y chromosome microdeletions were not found in any of the azoospermic KFS patients. In view of the hormonal and genetic abnormalities in infertile men with idiopathic NOA and with azoospermic KFS, genetic testing for karyotype, Y chromosome microdeletions, and hormonal parameters is advocated.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Idiopathic nonobstructive azoospermia; Karyotype; Klinefelter syndrome; Reproductive hormones; Y chromosome microdeletions

Mesh:

Substances:

Year:  2018        PMID: 29466784     DOI: 10.1159/000487039

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  7 in total

Review 1.  Y-Chromosome Microdeletions: A Review of Prevalence, Screening, and Clinical Considerations.

Authors:  Matthew J Rabinowitz; Phillip J Huffman; Nora M Haney; Taylor P Kohn
Journal:  Appl Clin Genet       Date:  2021-02-12

Review 2.  Antioxidant-Based Therapies in Male Infertility: Do We Have Sufficient Evidence Supporting Their Effectiveness?

Authors:  Angela Maria Amorini; Ilaria Listorti; Gabriele Bilotta; Romina Pallisco; Miriam Wissam Saab; Renata Mangione; Benedetta Manca; Giacomo Lazzarino; Barbara Tavazzi; Giuseppe Lazzarino; Pasquale Bilotta
Journal:  Antioxidants (Basel)       Date:  2021-02-02

3.  46XX Testicular Disorder of Sex Development.

Authors:  Krishna Chaitanya Mantravadi; Durga Gedela Rao
Journal:  J Hum Reprod Sci       Date:  2021-12-31

Review 4.  The Role of Genetics and Oxidative Stress in the Etiology of Male Infertility-A Unifying Hypothesis?

Authors:  Robert John Aitken; Mark A Baker
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

5.  The Spectrum of Chromosomal Abnormalities and Endocrine Profile of Male Infertility with Nonobstructive Semen Abnormality: A Case-Control Study.

Authors:  Paresh Singhal; Ganesh Pendkur; Rituraj Singh Parihar; Sharanjit Singh; Barun Kumar Chakrabarty; S K Raghavendra
Journal:  J Hum Reprod Sci       Date:  2021-06-28

6.  Expression of G-Protein-Coupled Estrogen Receptor (GPER) in Whole Testicular Tissue and Laser-Capture Microdissected Testicular Compartments of Men with Normal and Aberrant Spermatogenesis.

Authors:  Renata Walczak-Jędrzejowska; Ewa Forma; Elżbieta Oszukowska; Magdalena Bryś; Katarzyna Marchlewska; Krzysztof Kula; Jolanta Słowikowska-Hilczer
Journal:  Biology (Basel)       Date:  2022-02-26

Review 7.  Investigating the Role of the microRNA-34/449 Family in Male Infertility: A Critical Analysis and Review of the Literature.

Authors:  Konstantinos Pantos; Sokratis Grigoriadis; Penelope Tomara; Ioanna Louka; Evangelos Maziotis; Agni Pantou; Nikolaos Nitsos; Terpsithea Vaxevanoglou; Georgia Kokkali; Ashok Agarwal; Konstantinos Sfakianoudis; Mara Simopoulou
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-01       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.